Cartesian Therapeutics, Inc.: directors' dealings · United States · SEC (Form 4) Explore the full directors' dealings record of Cartesian Therapeutics, Inc., a publicly traded company based in United States. Shares are listed on US US, under the oversight of SEC (Form 4). Market capitalisation: €195.7m. The latest transaction was filed on 14 May 2025 (Levée d'options). Among the most active insiders: SPRINGER TIMOTHY A. Every trade is free.
€399,574
7 ops.
Sell Volume
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Last declaration on 14 May 2025
All Executives70 Thresholds0 Prospectus0 Other0
Declarations 70 total
◇ Chief Operations Officer · Executives · 12 May 2025
7,500 shares @ US$3.30 26.9% of flow Common Stock SEC:0001453687-25-000089:0
◇ Chief Operations Officer · Executives · 15 Apr 2025
7,500 shares @ US$3.30 26.4% of flow Common Stock SEC:0001453687-25-000068:0
▲ Director · Executives · 9 Apr 2025
7,342 shares @ US$9.4264 0.1% of flow Common Stock SEC:0001453687-25-000066:0
Ideal exit: 4 Jan 2026 (T+270) ▲ Director · Executives · 18 Mar 2025
14,740 shares @ US$14.4233 0.4% of flow Common Stock SEC:0001453687-25-000062:0
Ideal exit: 13 Dec 2025 (T+270) ▲ Director · Executives · 13 Jan 2025
7,962 shares @ US$16.8576 0.3% of flow Common Stock SEC:0001453687-25-000047:0
Ideal exit: 10 Oct 2025 (T+270) ◇ Chief Scientific Officer · Executives · 10 Jan 2025
9,000 shares @ US$3.23 14.0% of flow Common Stock SEC:0001453687-25-000045:0
▼ Chief Financial Officer · Executives · 3 Jan 2025
3,961 shares @ US$16.7219 100.0% of flow Common Stock SEC:0001453687-25-000035:0
▼ Chief Medical Officer · Executives · 3 Jan 2025
932 shares @ US$16.7219 12.4% of flow Common Stock SEC:0001453687-25-000039:0
▼ Chief Operations Officer · Executives · 3 Jan 2025
891 shares @ US$16.7219 17.5% of flow Common Stock SEC:0001453687-25-000037:0
▼ Chief Scientific Officer · Executives · 3 Jan 2025
1,264 shares @ US$16.7219 10.2% of flow Common Stock SEC:0001453687-25-000038:0
▼ Chief Technology Officer · Executives · 3 Jan 2025
2,417 shares @ US$16.7219 44.4% of flow Common Stock SEC:0001453687-25-000040:0
▼ President and CEO · Executives · 3 Jan 2025
8,563 shares @ US$16.7219 56.8% of flow Common Stock SEC:0001453687-25-000036:0
◆ Director · Executives · 2 Jan 2025
2,600 shares 0Common Stock SEC:0001453687-25-000020:0
◆ Director · Executives · 2 Jan 2025
2,600 shares 0Common Stock SEC:0001453687-25-000017:0
◆ Chief Scientific Officer · Executives · 2 Jan 2025
16,100 shares 0Common Stock SEC:0001453687-25-000027:0
◆ Director · Executives · 2 Jan 2025
2,600 shares 0Common Stock SEC:0001453687-25-000021:0
◆ Director · Executives · 2 Jan 2025
2,600 shares 0Common Stock SEC:0001453687-25-000019:0
◆ Director · Executives · 2 Jan 2025
2,600 shares 0Common Stock SEC:0001453687-25-000016:0
◆ Chief Medical Officer · Executives · 2 Jan 2025
19,000 shares 0Common Stock SEC:0001453687-25-000023:0
◆ Director · Executives · 2 Jan 2025
2,600 shares 0Common Stock SEC:0001453687-25-000022:0
◆ Director · Executives · 2 Jan 2025
2,600 shares 0Common Stock SEC:0001453687-25-000024:0
◆ Chief Financial Officer · Executives · 2 Jan 2025
22,000 shares 0Common Stock SEC:0001453687-25-000025:0
◆ Chief Technology Officer · Executives · 2 Jan 2025
16,100 shares 0Common Stock SEC:0001453687-25-000018:0
◆ Chief Operations Officer · Executives · 2 Jan 2025
16,100 shares 0Common Stock SEC:0001453687-25-000026:0
◆ Director · Executives · 2 Jan 2025
2,600 shares 0Common Stock SEC:0001453687-25-000015:0
25 of 70 declarations
Load more (45 remaining)